MedPath

铂生卓越生物科技(北京)有限公司

Ownership
-
Established
2010-05-18
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Amimestrocel Injection

Product Name
睿铂生
Approval Number
国药准字S20250001
Approval Date
Jan 2, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.